January 30, 2015 4:15 PM ET

Pharmaceuticals

Company Overview of NanoBio Corporation

Executive Profile

Lawrence R. Stanberry M.D., Ph.D.

Member of the Advisory Board, NanoBio Corporation
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background

Dr. Lawrence R. Stanberry, also known as Larry, MD, PhD serves as Professor and Chairman of Pediatrics and Director of Sealy Center for Vaccine Development of University of Texas Medical School, Galveston. Dr. Stanberry is a national recognized expert in the development of vaginal microbicides and vaccines for the prevention of genital herpes. His expertise lies in the fields of vaccine development and immunology, thus adding further expertise to the SAB. He serves as ...

Corporate Headquarters

2311 Green Road
Ann Arbor, Michigan 48105

United States

Phone: 734-302-4000
Fax: 734-302-9150

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NanoBio Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.